Terrence C Kearney Insider Trading $VRTX VERTEX PHARMACEUTICALS INC / MA
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Terrence C Kearney.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Terrence C Kearney. Terrence C Kearney is Director in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and Director in Innoviva, Inc. ($THRX) and SVP, Finance and CFO in HOSPIRA INC ($HSP) and Director in ACCELERON PHARMA INC ($XLRN) and Director in AveXis, Inc. ($AVXS).
Terrence C Kearney in VERTEX PHARMACEUTICALS INC / MA
Trading Symbol: VRTXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Terrence C Kearney: Director
Holdings: 10,811 shares
Current Value: $938,827
Latest Transaction: May 04 2021
$VRTX Market Capitalization: $21.78B
$VRTX Previous Close: $86.84
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Terrence C Kearney in VERTEX PHARMACEUTICALS INC / MA
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, XLRN, AVXS, HSP, THRX, VRTX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 04 2021 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Option Exercise | A | 217.20 | 6,067 | 1,317,752 | 6,067 | |
Jun 03 2020 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Option Exercise | A | 286.27 | 4,527 | 1,295,944 | 4,527 | |
Jun 04 2019 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Grant | A | 0.00 | 2,381 | 0 | 10,811 | 8.4 K to 10.8 K (+28.24 %) |
Jun 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Option Exercise | A | 152.74 | 3,229 | 493,197 | 3,229 | |
Jun 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Grant | A | 0.00 | 1,801 | 0 | 8,430 | 6.6 K to 8.4 K (+27.17 %) |
Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Option Exercise | M | 125.71 | 5,295 | 665,634 | 5,295 | |
Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Grant | A | 0.00 | 2,188 | 0 | 6,629 | 4.4 K to 6.6 K (+49.27 %) |
Jun 03 2016 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Option Exercise | A | 93.51 | 7,073 | 661,396 | 7,073 | |
Jun 03 2016 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Grant | A | 0.01 | 2,941 | 29 | 4,441 | 1.5 K to 4.4 K (+196.07 %) |
Jun 03 2015 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Option Exercise | A | 127.54 | 20,000 | 2,550,800 | 20,000 | |
May 21 2015 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Option Exercise | M | 56.99 | 1,500 | 85,485 | 375 | |
May 21 2015 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Buy | M | 56.99 | 1,500 | 85,485 | 1,500 | 0 to 1.5 K |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Option Exercise | M | 59.55 | 20,000 | 1,191,000 | 0 | |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Option Exercise | M | 53.85 | 20,000 | 1,077,000 | 0 | |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Option Exercise | M | 56.99 | 28,125 | 1,602,844 | 1,875 | |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Sell | S | 133.63 | 2,300 | 307,349 | 0 | 2.3 K to 0 (-100.00 %) |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Sell | S | 132.82 | 5,668 | 752,824 | 2,300 | 8 K to 2.3 K (-71.13 %) |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Sell | S | 131.76 | 3,969 | 522,955 | 7,968 | 11.9 K to 8 K (-33.25 %) |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Sell | S | 130.58 | 8,800 | 1,149,104 | 11,937 | 20.7 K to 11.9 K (-42.44 %) |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Sell | S | 129.94 | 4,500 | 584,730 | 20,737 | 25.2 K to 20.7 K (-17.83 %) |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Sell | S | 128.12 | 16,295 | 2,087,715 | 25,237 | 41.5 K to 25.2 K (-39.23 %) |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Sell | S | 127.50 | 26,593 | 3,390,608 | 41,532 | 68.1 K to 41.5 K (-39.04 %) |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Buy | M | 59.55 | 20,000 | 1,191,000 | 68,125 | 48.1 K to 68.1 K (+41.56 %) |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Buy | M | 53.85 | 20,000 | 1,077,000 | 48,125 | 28.1 K to 48.1 K (+71.11 %) |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Buy | M | 56.99 | 28,125 | 1,602,844 | 28,125 | 0 to 28.1 K |
Page: 1